Trial intelligence / Profile preview

Comparison of ImaTx and DXA Imaging in Postmenopausal Osteoporosis Treated with PTH(1-84)

NCT00583518Phase 4Completed

Sponsor
Nycomed
Start
Nov 2007
Primary completion
Nov 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of parathyroid hormone 1-84 in osteoporosis, sponsored by Nycomed. Started Nov 2007; status: completed.

02

Drugs

parathyroid hormone 1-84
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT00583518.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00583518.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call